Insmed (INSM) EBITDA Margin (2011 - 2026)
Insmed (INSM) recorded EBITDA Margin of 1.21% in Q2 2026, up 287.44 percentage points from -286.23% a year earlier and up 49.23 percentage points from the prior quarter.
Powered by 
Analysis
Insmed (INSM) EBITDA Margin (2011 - 2026) Analysis & Trends
On a TTM basis, Insmed's EBITDA Margin came in at -71.66% as of Jun 30, 2026, up 175.94 percentage points year-over-year; for FY2025, it came in at -201.86%, up 34.68 percentage points from FY2024.
- Annual EBITDA Margin has a five-year change of -49.99 percentage points (FY2020 to FY2025).
- Across earlier years, EBITDA Margin came in at -236.54% in FY2024 (-9.90 pp), -226.64% in FY2023 (-46.10 pp), -180.54% in FY2022 (+9.96 pp) and -190.50% in FY2021 (-38.64 pp).
- The Q2 2026 figure is the highest quarterly EBITDA Margin in data going back to Q1 2011.
- On a year-over-year basis, EBITDA Margin has increased for three consecutive quarters, with an average year-over-year change of +58.89 percentage points over the last eight quarters.
- Peak year-over-year performance for EBITDA Margin in the last five years was a gain of 287.44 percentage points in Q2 2026, against a drop of 168.30 percentage points in Q2 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at -48.02% (Q1 2026), -118.56% (Q4 2025) and -253.38% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 54.65% |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 32.68% |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 46.88% |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 40.75% |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 46.62% |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 50.63% |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 42.49% |
| 10 | Insmed | 25.82 Bn | 20.86 Bn | 446.21 Mn | -15.16% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -15.16% |
| Jun 30, 2026 | 1.21% |
| Mar 31, 2026 | -48.02% |
| Dec 31, 2025 | -118.56% |
| Sep 30, 2025 | -253.38% |
| Jun 30, 2025 | -286.23% |
| Mar 31, 2025 | -261.97% |
| Dec 31, 2024 | -216.28% |
| Sep 30, 2024 | -223.95% |
| Jun 30, 2024 | -314.82% |
| Mar 31, 2024 | -186.49% |
| Dec 31, 2023 | -207.64% |
| Sep 30, 2023 | -180.94% |
| Jun 30, 2023 | -299.05% |
| Mar 31, 2023 | -220.69% |
| Dec 31, 2022 | -247.02% |
| Sep 30, 2022 | -184.20% |
| Jun 30, 2022 | -130.75% |
| Mar 31, 2022 | -162.81% |
| Dec 31, 2021 | -206.44% |
API Access
Insmed EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=INSM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "INSM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=INSM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();